Oxford Genetics Licenses CRISPR Gene Editing Technology from ERS Genomics to extends its synthetic biology … – Benzinga
|
Oxford Genetics Licenses CRISPR Gene Editing Technology from ERS Genomics to extends its synthetic biology …
Benzinga Licensing the CRISPR gene editing technology from ERS Genomics is another step on our journey to establishing the most efficient and integrated service portfolio in this sector," commented Dr. Paul Brooks, Ph.D., CCO, Oxford Genetics. "We are excited … |
